The rise of IL-2 therapy - a picture beyond T_reg cells

Nat Rev Rheumatol. 2017 Jun;13(6):386. doi: 10.1038/nrrheum.2017.70. Epub 2017 May 11.

Authors

Zhanguo Li¹, Jing He¹, Di Yu²

Affiliations

¹ Department of Rheumatology and Immunology, Peking University People's Hospital, 11 Xizhimen South Street, 100044, Beijing, China.
² Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, ACT 0200, Australia.

PMID: 28490785
DOI: 10.1038/nrrheum.2017.70

No abstract available

Publication types

Comment

MeSH terms

Humans
Immunotherapy
Interleukin-2*
Lupus Erythematosus, Systemic*
T-Lymphocyte Subsets
T-Lymphocytes, Regulatory

Substances

Interleukin-2